Researchers Developing Nipah Virus Vaccine, To Begin Clinical Trial In April

A team of researchers in Japan is developing a vaccine for Nipah virus in humans and plans to conduct a clinical trial in April.

The University of Tokyo researchers will test the vaccine candidate in Belgium.

There is currently no vaccine for Nipah virus, which has an estimated fatality rate between 40 and 75 percent.

Nipah virus vaccine from University of Tokyo set for April clinical trial https://t.co/N1hgltjmld

— Nikkei Asia (@NikkeiAsia) January 31, 2026

Reports of a Nipah virus outbreak in an Indian state prompted airports across Asia to implement COVID-style screenings.

Airports introduced precautionary measures after two Nipah virus cases were confirmed in India’s West Bengal.

Deadly Illness Reportedly Detected In Asia, Prompting Airports To Implement Screening Measures Similar To COVID-19